34 research outputs found
Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice
Improvement of bone allograft recolonization by adipose stem cells: impact of bone graft demineralization
Bone allografts combined with mesenchymal stem cells are
proposed for bone tissue engineering but remains limited by a
low degree of stem cells spreading and cellular recolonization.
We postulate to demineralize bone allografts in view to improve
adipose stem cells (ASCs) colonization and the bioactivity of
the graft.
Bone allografts (n=16) were treated for decellularization (4
groups of demineralization time: 0, 4, 8, 12 hours). The implants
were compared in terms of residual calcium, mineral density
and bioactivity (for BMP-2/VEGF contents). Each implant was
scanned by microtomography to analyze macroporosity and
open porosity. Helium pycnometry and Hg porosimetry were
performed to assess the absolute density and microporosity.
Bone surface analysis was assessed by X-Ray photoelectron
spectroscopy and SEM. The bone graft recolonization by ASCs
was studied in vitro by SEM, histology and DNA extraction at
24 hours/day 15 post-cellular seeding. Finally, ASCs combined
with non-/demineralized bone matrix were implanted into
the lumbar muscles of 10 nude rats (in comparison to bone
grafts w/o cells) to study the osteoinductivity/angiogenicity by
imagery/histology 29 days after implantation.
A significant reduction of the calcium concentration (>-90%)
was found in demineralized bone in comparison to native grafts
as revealed by ionometry (0.27 vs. 4.1 g/L) and pQCT (0 vs. 0.39 g/
cm?). Demineralization significantly increase the macroporosity
(>100μm by +13%) and the open porosity (>4 cm?/g vs. 2.1±1.0
cm?/g in comparison to the native graft,p<0.05). A significant
increase of microporosity (>10 μm by +158% and <100 nm
by 558%) was also found after demineralization. Helium
pycnometry confirmed the correlation between the decrease
of absolute density and demineralization of the bone graft
(R?=0.81). A positive linear correlation between the decrease of
calcium/increase of nitrogen atoms (at the bone surface) and
the time of demineralization was found (R?=0.99,p<0.001). At
day 15 post-incubation, a significant higher ASCs colonization
of the bone graft was found for tissue demineralized during 12
hours (p<0.05).
In conclusion, the demineralization of cancellous bones
significantly improves the colonization by ASCs in view to
return the bioactivity for bone regeneration
Expiratory flow limitation during sleep in heavy snorers and obstructive sleep apnoea patients
Inspiratory flow limitation (FL) during sleep has previously been reported both in obstructive sleep apnoea (OSA) patients and heavy snorers (HS), Recent results from this laboratory have shown the occurrence both of inspiratory and expiratory flow limitation during muscular relaxation in awake healthy subjects and OSA patients.
In this study, we have investigated whether expiratory flow limitation occurs during sleep in heavy snorers and in patients with OSA, We studied four nonapnoeic, heavy snorers and five OSA patients, Airflow was measured with a pneumotachograph attached to a tight-fitting mask, and supraglottic pressure with a catheter placed at the supraglottic level, Scoring for flow limitation was achieved by visual inspection of 200 breaths recorded during sleep.
About 20% of the respiratory cycles presented isolated inspiratory flow limitation, Approximately the same percentage was observed in heavy snorers and OSA patients, Isolated expiratory flow limitation was less frequently recorded, Coupled inspiratory and expiratory flow limitations were more numerous, especially in heavy snorers.
We conclude that both in heavy snorers and obstructive sleep apnoea patients, inspiratory flow limitation is associated with expiratory now limitation, This suggests that upper airway obstruction during sleep is both an inspiratory and expiratory event
Bioactivity of a tissue-engineered product: bridging the gap between academic and clinical studies
The translation of cell-based therapeutics from academic and fundamental sciences to clinical trial settings follows a preclinical pathway with rigorous regulatory oversights to ensure the cellmediated therapeutic effect. Although international guidelines thoroughly describe single-dose toxicity and biodistribution studies, the quantitative evaluation of the biological activity remains a major challenge for biotechnology companies and authorities. Here we discuss a strategy to demonstrate the bioactivity of an osteogenic tissue-engineered product intended to promote angiogenesis and osteogenesis in a bone defect. Osteogenic 3-dimensional (3D) grafts were manufactured as a pharmaceutical batch. A sequence of chemical treatment was applied on the native graft in view to obtained a decellularized 3D-matrix as confirmed by a reduction of >90% and 40-80% of the cellular and growth factors (VEGF, IGF1) contents, respectively. Decellularized and native grafts were implanted intra-muscularly (after cauterization of the lumbar region, n=10 nude rats) to assess the mineralization (X-ray microCT and histomorphometry on Von Kossa staining) and angiogenesis (histomorphometry on Masson’s Trichrome and Von Willebrand Factor immunostaining) at day 29 postimplantation. Human cells detection (in the explanted tissue) were also quantified after KU80/HLA type I immunostaining at the implantation site. A significant higher mineralization was found for explanted samples from the native osteogenic 3D grafts in comparison to the decellularized tissues (Bone volume/tissue volume of 2.92 ± 1.12% vs. 0.38 ± 0.59%, respectively
An allogenic 3D scaffold-free tissue engineered product for deep thickness skin regeneration: in vitro development to in vivo proof of concept
A scaffold-free graft for large critical size bone defect: preclinical evidence to clinical proof of concept
Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.
BACKGROUND: Smoking may cause inflammation of the airways and impairment of lung function. To determine the relationship between the type and degree of airways inflammation and the decline in lung function, leucocytes in the sputum of smokers and ex-smokers were examined. METHODS: Forty six smokers and ex-smokers of median age 64 years (25%; 75% percentiles 62;66) with a smoking history of 40.1 (31.7;53) pack years were studied with lung function tests and a questionnaire at the end of a 15 year follow up period. Sputum was induced by inhalation of hypertonic saline and differential leucocyte counts were performed on cytospin preparations. RESULTS: Adequate sputum samples were obtained in 38 subjects (78%). The ratio of forced expiratory volume in one second (FEV1) to vital capacity (VC) was 67.1 (60; 72)% and the annual decline in FEV1 was 19.4 (12;30) ml/year. Subjects with airways obstruction (FEV1/VC < 63%) had more neutrophils (77 (50;86)%) than those without airways obstruction (60 (43;73)%). The percentage of neutrophils was also significantly greater (77 (62;85)%) in those with chronic expectoration than in those without expectoration (57 (45;75)%. Increased levels of neutrophils in the sputum were correlated with a rapid decline in FEV1 over the 15 year follow up period. CONCLUSIONS: Airways obstruction and chronic expectoration, as well as accelerated decline in lung function, are associated with increased numbers of neutrophils in the sputum of smokers and ex-smokers which suggests that neutrophilic inflammation of the airways may be involved in the pathogenesis of chronic obstructive pulmonary disease
